By applying robotics and artificial intelligence to cerebral ultrasound, NovaSignal uniquely captures blood flow data in real time. The NovaSignal Platform empowers the clinical team with critical, real-time information about cerebral blood flow to guide diagnosis and improve patient outcomes.
More than 75% of the global burden of SCD occurs in sub-Saharan Africa, where an estimated 1.03 million children are afflicted. Learn more about how Dr. Nicole O’Brien and Nationwide Children’s Hospital is using TCD to help treat SCD in Africa!
Access to real-time data can prevent disability or death. With more than 200 clinical studies published annually, indications for the use of cerebral ultrasound (also referred to as TCD) are expanding.
The prevalence of PFO among the cryptogenic stroke population is ~40% to 50%. ¹
Vasospasm has been reported in as many as 70% of patients after a subarachnoid hemorrhage. ³
It is estimated that every year up to 600,000 patients in the U.S. suffer a stroke during, or after, a cardiovascular procedure. ⁵
A comprehensive solution designed to seamlessly integrate into existing clinical practice. The NovaSignal Platform empowers the clinical team with critical information about cerebral blood flow to guide diagnosis and improve patient outcomes.
Offering secure, cloud-based access to dynamic exam data, NovaGuide View improves coordination of clinical teams, reduces time to intervention, and is a critical piece of the overall patient assessment.
With cutting-edge AI and advanced robotics, the NovaGuide 2 Intelligent Ultrasound uniquely captures blood flow data in real-time to identify brain illnesses and diseases that present as changes in cerebral blood flow.
NovaKit 2 provides required essentials to ensure exams are safe, comfortable, and personalized for each patient.
NovaCare provides certified service and support for the NovaSignal Platform, including 24/7 remote support, IT integration, on-site servicing, loaner devices, and more.
NovaSignal is committed to advancing patient care through innovative, evidence-based solutions for patients and providers.
“Integrating the NovaGuide gives clinicians a chance to look inside the brain at blood flow patterns in real time and rapidly identify physiological changes associated with neurological disorders, enabling efficient diagnosis and triage for treatment.”
Dr. Alan B. Lumsden
Medical Director and Chair of Cardiovascular Surgery
Houston Methodist DeBakey Heart and Vascular Center
“It is remarkable that a diagnostic machine used to study the brain could give us insight into the pathophysiology of a pulmonary disease. The benefit of using this particular system was that automated monitoring allowed providers to assess cerebral blood flow while minimizing the potential for exposure to COVID-19.”
Dr. Alex Reynolds
Neurocritical Intensivist and Asst Professor of Neurology
Icahn School of Medicine at Mount Sinai
“NovaSignal’s solution, including the automated ultrasound and cloud application, provide unsurpassed access and accuracy for cryptogenic stroke management and PFO assessment.”
Dr. Andrei V. Alexandrov
Semmes-Murphey Professor and Chairman of Neurology
University of Tennessee Memphis
NovaSignal is committed to providing safe and effective solutions for assessing brain health that adhere to all statutory and regulatory requirements. Our products meet FDA regulations, ISO 13485:2016 standards, and MDSAP requirements for quality management systems.